We are live on ! Find out more
ATHE

Alterity Therapeutics
ATHE

21 hedge funds and large institutions have $3.45M invested in Alterity Therapeutics in 2013 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 6 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,200% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 1

596% more capital invested

Capital invested by funds: $496K → $3.45M (+$2.96M)

110% more funds holding

Funds holding: 10 → 21 (+11)

63% less call options, than puts

Call options by funds: $91K | Put options by funds: $245K

Holders
21
Holders Change
+11
Holders Change %
+110%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
6
Reduced
–
Closed
1
Calls
$91K
Puts
$245K
Net Calls
-$154K
Net Calls Change
-$154K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$624K
2
Morgan Stanley
Morgan Stanley
New York
+$612K
3
PA
Para Advisors
New York
+$191K
4
Federated Hermes
Federated Hermes
Pennsylvania
+$153K
5
Jane Street
Jane Street
New York
+$127K

Top Sellers

Rank Fund Capital Flow
1
ARTA
A.R.T. Advisors
New York
-$31K

ATHE Hedge Fund Activity: Q3 2013 in Review

21 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q3 2013, worth a combined $3.45M — up 596% from $496K a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new ATHE positions and 1 closed out — a net gain of 12 holders — while 6 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $624K. The largest seller was A.R.T. Advisors, exiting entirely with an estimated $31K sold.

  • 21 institutional investors held Alterity Therapeutics (ATHE) as of Q3 2013, up from 10 in Q2 2013.
  • Funds reported $3.45M of Alterity Therapeutics stock for Q3 2013, up 596% quarter-over-quarter.
  • 13 funds opened new Alterity Therapeutics positions in Q3 2013 and 1 closed out, a net change of +12 holders.
  • The largest Alterity Therapeutics buyer in Q3 2013 was Renaissance Technologies, an estimated $624K added.
  • The largest Alterity Therapeutics seller in Q3 2013 was A.R.T. Advisors, an estimated $31K sold.

Based on aggregated 13F filings for Q3 2013.